Skip to main content

Table 1 Benchmarking pDOCK with our earlier methodology.

From: pDOCK: a new technique for rapid and accurate docking of peptide ligands to Major Histocompatibility Complexes

S. No.

Allele

PDB

Peptide Length

Peptide Sequence

Cα RMSD (Å)

     

Previous method

pDOCK

MHC-I

      

1

HLA-A*1101

1qvo

10

QVPLRPMTYK

0.53

0.24

2

HLA-A*0201

1qr1

9

IISAVVGIL

0.46

0.29

3

HLA-A*0201

1akj

9

ILKEPVHGV

0.87

0.39

4

HLA-A*0201

1i1y

9

YLKEPVHGV

0.70

0.66

5

HLA-A*0201

1i7r

9

FAPGFFPYL

0.59

0.47

6

HLA-A*0201

1i7u

9

ALWGFVPVL

0.32

0.29

7

HLA-A*0201

1oga

9

GILGFVFTL

0.32

0.16

8

HLA-A*0201

1qsf

9

LLFGYPVAV

0.54

0.34

9

HLA-A*0201

1lp9

9

ALWGFFPVL

0.58

0.26

10

HLA-A*0201

1s9y

9

SLLMWITQS

1.09

0.39

11

HLA-A*0201

1hhh

10

FLPSDFFPSV

1.10

0.49

12

HLA-A*0201

1jf1

10

ELAGIGILTV

1.53

0.30

13

HLA-B*0801

1agc

8

GGKKKYQL

0.28

0.23

14

HLA-B*0801

1mi5

9

FLRGRAYGL

0.42

0.37

15

HLA-B*2705

1ogt

9

RRKWRRWHL

0.51

0.18

16

HLA-B*2705

2a83

9

RRRWHRWRL

0.55

0.18

17

HLA-B*3501

2cik

9

KPIVVLHGY

0.74

0.26

18

HLA-B*3508

3bwa

8

FPTKDVAL

0.56

0.26

19

HLA-B*5101

1e27

9

LPPVVAKEI

1.27

0.18

20

HLA-B*5301

1a1m

9

TPYDINQML

0.59

0.28

21

HLA-Cw*0401

1im9

9

QYDDAVYKL

0.49

0.34

22

HLA-G*0101

2dyp

9

RIIPRHLQL

0.43

0.16

23

H2-Db

1fg2

9

KAVYNFATC

0.25

0.19

24

H2-Db

3buy

9

LSLRNPILV

0.63

0.23

25

H2-Db

1yn7

10

SSLENFAAYV

0.62

0.14

26

H2-Db

1jpf

11

SGVENPGGYCL

1.14

0.36

27

H2-Dd

1qo3

10

RGPGRAFVTI

1.49

0.17

28

H2-Kb

1t0m

8

SSIEFARL

0.66

0.21

29

H2-Kb

1vac

8

SIINFEKL

0.32

0.22

30

H2-Kb

1wbz

9

SSYRRPVGI

0.89

0.19

31

H2-Kb

1s7q

9

KAVYNFATM

0.20

0.09

32

H2-Kb

1g7p

9

SRDHSRTPM

0.97

0.17

33

H2-Kd

1vgk

9

SYVNTNMGL

0.86

0.25

34

H2-Kk

1zt1

8

FEANGNLI

0.57

0.45

35

H2-Ld

2e7l

9

QLSPFPFDL

0.37

0.35

MHC-II

      

36

HLA-DQB1*0602

1uvq

20

MNLPSTKVSWAAVGGGGSLV

1.09

0.23

37

HLA-DRB1*0301

1a6a

15

PVSKMRMATPLLMQA

0.38

0.30

38

HLA-DRB1*0101

1aqd

14

GSDWRFLRGYHQYA

1.08

0.28

39

HLA-DRB1*0101

1fyt

13

PKYVKQNTLKLAT

0.68

0.23

40

HLA-DRB1*0101

2iam

15

GELIGILNAAKVPAD

0.56

0.24

41

HLA-DRB1*0401

1d5x

6

XXRXXX

0.23

0.11

42

HLA-DRB1*0401

1d5z

7

XXRAXSX

0.33

0.22

43

HLA-DRB1*0401

1d6e

8

XXRXMASX

0.32

0.14

44

HLA-DRB1*0401

1j8h

13

PKYVKQNTLKLAT

0.59

0.20

45

HLA-DRB3*0101

2q6w

11

AWRSDEALPLG

0.54

0.30

46

HLA-DRB5*0101

1fv1

20

NPVVHFFKNIVTPRTPPPSQ

0.88

0.59

47

I-Ad

1iao

14

RGISQAVHAAHAEI

0.81

0.27

48

I-Ak

1iak

13

STDYGILQINSRW

0.42

0.23

49

I-Au

2pxy

11

RGGASQYRPSQ

0.78

0.28

50

I-Ek

1r5v

13

ADLIAYPKAATKF

0.82

0.28

  1. Cα RMSD values are calculated only for the nonamer binding cores (shown in bold) for peptides with more than 9 residues in the X-ray crystal structures. X: Amino acid analogues (chemical mimics). A graphical representation of the results is available in Additional File 2 – Figure S1.